TTK and breast cancer: MPS-1 exhibits heightened expression levels across various cancer types, including breast cancer [12], hepatocellular carcinoma [13], pancreatic cancer [14], and gastric cancer [15], and its overexpression is mostly correlated with unfavorable patient prognosis.